Young Alethia, CFO of Bicycle Therapeutics PLC ($BCYC), made seven open market sales of company shares over the last year, totaling $57,762. Her most recent sale occurred on January 5, 2026. These transactions rank her 10,237th out of 11,678 insiders by sale value, far below the average of $8.6 million across 6.4 sales per insider. She reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | PTC THERAPEUTICS, INC. | $PTCT | Young Alethia | Not found | A | Common Stock | 4000 | $0.00 | 21,067.0000 | 88,311,494 | 23.44% | 0.00% |
| Jan. 2, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Young Alethia | Chief Financial Officer | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 69,303,746 | 9999.99% | 0.14% |
| Jan. 5, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Young Alethia | Chief Financial Officer | S | Ordinary Shares | 1878 | $6.54 | 87,081.0000 | 69,303,746 | 2.11% | 0.00% |
| Jan. 5, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Young Alethia | Chief Financial Officer | S | Ordinary Shares | 2456 | $6.45 | 88,959.0000 | 69,303,746 | 2.69% | 0.00% |
| Jan. 2, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Young Alethia | Chief Financial Officer | S | Ordinary Shares | 3289 | $6.80 | 91,415.0000 | 69,303,746 | 3.47% | 0.00% |
| Jan. 2, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Young Alethia | Chief Financial Officer | A | Ordinary Shares | 50000 | $0.00 | 94,704.0000 | 69,303,746 | 111.85% | 0.07% |
| Jan. 2, 2026 | PTC THERAPEUTICS, INC. | $PTCT | Young Alethia | Not found | A | Stock Option (Right to Buy) | 3475 | $0.00 | 3,475.0000 | 88,311,494 | 9999.99% | 0.00% |
| Oct. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Young Alethia | Chief Financial Officer | S | Ordinary Shares | 265 | $8.61 | 44,704.0000 | 69,303,746 | 0.59% | 0.00% |
| Oct. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Young Alethia | Chief Financial Officer | S | Ordinary Shares | 217 | $8.40 | 44,969.0000 | 69,303,746 | 0.48% | 0.00% |
| July 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Young Alethia | Chief Financial Officer | S | Ordinary Shares | 204 | $7.09 | 45,186.0000 | 69,252,009 | 0.45% | 0.00% |
| June 11, 2025 | Pacira BioSciences, Inc. | $PCRX | Young Alethia | Director | A | Stock Option (Right to Buy) | 11279 | $0.00 | 11,279.0000 | 46,245,000 | 9999.99% | 0.02% |
| June 11, 2025 | Pacira BioSciences, Inc. | $PCRX | Young Alethia | Director | A | Common Stock | 6163 | $0.00 | 11,393.0000 | 46,245,000 | 117.84% | 0.01% |
| April 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Young Alethia | Chief Financial Officer | S | Ordinary Shares | 215 | $8.02 | 45,390.0000 | 69,196,945 | 0.47% | 0.00% |
| Jan. 3, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Young Alethia | Not found | A | Common Stock | 4000 | $0.00 | 17,067.0000 | 76,845,055 | 30.61% | 0.01% |
| Jan. 3, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Young Alethia | Not found | A | Stock Option (Right to Buy) | 8800 | $0.00 | 8,800.0000 | 76,845,055 | 9999.99% | 0.01% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Young Alethia | Chief Financial Officer | S | Ordinary Shares | 1395 | $14.09 | 45,605.0000 | 58,207,593 | 2.97% | 0.00% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Young Alethia | Chief Financial Officer | A | Ordinary Shares | 35000 | $0.00 | 47,000.0000 | 58,207,593 | 291.67% | 0.06% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Young Alethia | Chief Financial Officer | A | Employee Stock Option (right to buy) | 87000 | $0.00 | 87,000.0000 | 58,207,593 | 9999.99% | 0.15% |
| June 12, 2024 | Pacira BioSciences, Inc. | $PCRX | Young Alethia | Director | A | Stock Option (Right to Buy) | 12179 | $0.00 | 12,179.0000 | 51,979,000 | 9999.99% | 0.02% |
| June 12, 2024 | Pacira BioSciences, Inc. | $PCRX | Young Alethia | Director | A | Common Stock | 5230 | $0.00 | 5,230.0000 | 51,979,000 | 9999.99% | 0.01% |
| Feb. 15, 2024 | PTC THERAPEUTICS, INC. | $PTCT | Young Alethia | Not found | A | Common Stock | 4000 | $0.00 | 13,067.0000 | 74,838,292 | 44.12% | 0.01% |
| Feb. 15, 2024 | PTC THERAPEUTICS, INC. | $PTCT | Young Alethia | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 74,838,292 | 9999.99% | 0.01% |
| Jan. 2, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Young Alethia | Chief Financial Officer | A | Ordinary Shares | 12000 | $0.00 | 12,000.0000 | 35,592,362 | 9999.99% | 0.03% |
| Jan. 2, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Young Alethia | Chief Financial Officer | A | Employee Stock Option (right to buy) | 24000 | $0.00 | 24,000.0000 | 35,592,362 | 9999.99% | 0.07% |
| Oct. 6, 2023 | Pacira BioSciences, Inc. | $PCRX | Young Alethia | Director | A | Stock Option (Right to Buy) | 30967 | $0.00 | 30,967.0000 | 46,538,000 | 9999.99% | 0.07% |
| Sept. 6, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Young Alethia | Not found | S | Common Stock | 4666 | $39.79 | 9,067.0000 | 74,730,433 | 33.98% | 0.01% |
| Sept. 6, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Young Alethia | Not found | M | Stock Option (Right to Buy) | 7000 | $27.85 | 10,000.0000 | 74,730,433 | 41.18% | 0.01% |
| Sept. 6, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Young Alethia | Not found | M | Stock Option (Right to Buy) | 4666 | $27.85 | 17,334.0000 | 74,730,433 | 21.21% | 0.01% |
| Sept. 6, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Young Alethia | Not found | M | Common Stock | 4666 | $27.85 | 13,733.0000 | 74,730,433 | 51.46% | 0.01% |
| Sept. 6, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Young Alethia | Not found | S | Common Stock | 7000 | $39.90 | 9,067.0000 | 74,730,433 | 43.57% | 0.01% |
| Sept. 6, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Young Alethia | Not found | M | Common Stock | 7000 | $27.85 | 16,067.0000 | 74,730,433 | 77.20% | 0.01% |
| July 17, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Young Alethia | Chief Financial Officer | A | Employee Share Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 30,191,693 | 9999.99% | 0.40% |
| Feb. 21, 2023 | LENZ Therapeutics, Inc. | $LENZ | Young Alethia | Chief Financial Officer | A | Stock Option (right to buy) | 220000 | $0.00 | 220,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Young Alethia | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 71,728,634 | 9999.99% | 0.01% |
| Jan. 5, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Young Alethia | Not found | A | Common Stock | 4000 | $0.00 | 9,067.0000 | 71,728,634 | 78.94% | 0.01% |